Abstract
The results in this short series show that early and prolonged α-interferon therapy for hepatitis C virus recurrence after liver transplantation could bring some benefit to the infected liver grafts. The risk of graft rejection was clearly minimised by maintaining immunosuppression at normal levels.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feray C, Gigou M, Samuel D, et al. (1994)Hepatology 20: 1137
Sarocco G, Rosina F, Abate ML, et al. (1993) Hepatology 18: 1300
Manabe N, Chevallier M, Chossegros P, et al. (1993) Hepatology 18: 1344
Wright TL, Coombs C, Kim M, et al. (1994) Hepatology 20: 773
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Boillot, O. et al. (1996). Effectiveness of early α-interferon therapy for hepatitis C virus infection recurrence after liver transplantation. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_51
Download citation
DOI: https://doi.org/10.1007/978-3-662-00818-8_51
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61024-3
Online ISBN: 978-3-662-00818-8
eBook Packages: Springer Book Archive